EASL Studio Podcast: Liver cancer care in 2025: Progress, hope, and what lies ahead
Join this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes. Moderator: Thomas Berg Faculty: Tim Greten and Anna Saborowski This EASL Studio is supported by Bayer. EASL has received no input from Bayer with regards to the content of this programme....